AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2024
Aug 26, 2024
34519_dirs_2024-08-26_ea40d2f5-d206-463a-8c56-6a6176c7db03.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2024-08-23
Reporting Person: Tomsche David Scott (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-23 | Common stock $0.10 per value per share | D | 6005 | $3.55 | Acquired | 129611 | Direct |
Footnotes
F1: (1) This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23